We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Cipher Pharmaceuticals Inc (CPH) - Financial and Strategic SWOT Analysis Review

Published: March 2019
Pages: 25
Code: 01FD56EFA07E12D59CA7E095F07D42AC
Format: PDF
Publisher GlobalData
From Add to basket
$ 300.00
Summary
Cipher Pharmaceuticals Inc (Cipher) is a pharmaceutical company that develops skin care solutions. The company provides products such as actikerall, a topical solution indicated for the treatment of hyperkeratotic actinic keratosis; beteflam, a topical patch used for the treatment of mild to moderate plaque psoriasis of the elbows and knee in adults; epuris, an oral retinoid indicated for the treatment of severe nodular and inflammatory acne; and vaniqa, a topical cream indicated to reduce the growth of unwanted facial hair in women. Its pipeline products under development can be used in the treatment of seborrheic dermatitis, plaque psoriasis, chronic pruritus, rheumatoid arthritis, late stage melanoma, and others. Cipher’s pre-clinical compounds are intended for the treatment of melanoma and other cancers. The company provides healthcare professionals with several non-prescription products. Cipher is headquartered in Mississauga, Ontario, Canada.
Cipher Pharmaceuticals Inc Key Recent Developments
Dec 04,2018: Cipher Pharmaceuticals adds new Vice President, Canadian commercial operations
Nov 07,2018: Cipher Pharmaceuticals reports Q3 2018 results
Oct 24,2018: Cipher Pharmaceuticals Announces Canadian Launch of Brinavess (vernakalant hydrochloride)
Sep 10,2018: Cipher Pharmaceuticals Receives Health Canada Approval of Xydalba™ (dalbavancin hydrochloride)[Newswire : Healthcare-CNW]
Aug 10,2018: Cipher Pharmaceuticals reports Q2 2018 results
This comprehensive SWOT profile of Cipher Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cipher Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • Table of Contents
  • Section 1 - About the Company
  • Cipher Pharmaceuticals Inc - Key Information
  • Cipher Pharmaceuticals Inc - Overview
  • Cipher Pharmaceuticals Inc - Key Employees
  • Cipher Pharmaceuticals Inc - Key Employee Biographies
  • Cipher Pharmaceuticals Inc - Key Operational Heads
  • Cipher Pharmaceuticals Inc - Major Products and Services
  • Cipher Pharmaceuticals Inc - History
  • Cipher Pharmaceuticals Inc - Company Statement
  • Cipher Pharmaceuticals Inc - Locations And Subsidiaries
  • Cipher Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Cipher Pharmaceuticals Inc - Business Description
  • Cipher Pharmaceuticals Inc - Corporate Strategy
  • Cipher Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cipher Pharmaceuticals Inc - Strengths
  • Cipher Pharmaceuticals Inc - Weaknesses
  • Cipher Pharmaceuticals Inc - Opportunities
  • Cipher Pharmaceuticals Inc - Threats
  • Cipher Pharmaceuticals Inc - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Cipher Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company
  • List of Tables
  • Cipher Pharmaceuticals Inc, Key Information
  • Cipher Pharmaceuticals Inc, Key Ratios
  • Cipher Pharmaceuticals Inc, Share Data
  • Cipher Pharmaceuticals Inc, Major Products and Services
  • Cipher Pharmaceuticals Inc, History
  • Cipher Pharmaceuticals Inc, Key Employees
  • Cipher Pharmaceuticals Inc, Key Employee Biographies
  • Cipher Pharmaceuticals Inc, Key Operational Heads
  • Cipher Pharmaceuticals Inc, Other Locations
  • Cipher Pharmaceuticals Inc, Subsidiaries
  • Cipher Pharmaceuticals Inc, Key Manufacturing facilities
  • Cipher Pharmaceuticals Inc, Key Competitors
  • Cipher Pharmaceuticals Inc, SWOT Analysis
  • Cipher Pharmaceuticals Inc, Ratios based on current share price
  • Cipher Pharmaceuticals Inc, Annual Ratios
  • Cipher Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Cipher Pharmaceuticals Inc, Performance Chart
  • Cipher Pharmaceuticals Inc, Ratio Charts

Keywords
;